Literature DB >> 9286221

Improvement in specificity of [14C]d-xylose breath test for bacterial overgrowth.

S J Lewis1, G Young, M Mann, S Franco, S J O'Keefe.   

Abstract

The aim of the study was to determine whether the specificity of the [14C]d-xylose breath test could be improved, by excluding false-positive tests due to premature colonic metabolism of the [14C]d-xylose caused by rapid colonic transit. Forty-seven patients with suspected small bowel bacterial overgrowth were investigated by (1) aspiration and culture of duodenal fluid and (2) a [14C]d-xylose breath test. Those with either a positive duodenal culture or breath test had a repeat [14C]d-xylose breath test given with one of three transit markers (barium, Gastrografin or 99mTc-labeled tin colloid) to determine if the site of metabolism was in the small bowel or colon. Fourteen patients had positive duodenal cultures, four of whom had a negative [14C]d-xylose breath test, 15 patients had a positive [14C]d-xylose breath test, three of which were due to colonic metabolism of the xylose. Where transit markers were used, 14C was detectable in the breath and serum before barium had entered the small bowel, thus the barium did not comigrate with the xylose. Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose. 99mTc-labeled tin colloid had no obvious disadvantages and appeared to be the marker of choice. The use of a transit marker increased the specificity of the [14C]d-xylose breath test from 85% to 94%. The specificity of the [14C]d-xylose breath test for the detection of small bowel bacterial overgrowth is improved to greater than 90% by the use of an appropriate transit marker.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286221     DOI: 10.1023/a:1018880524829

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Small intestine bacterial overgrowth.

Authors:  C E King; P P Toskes
Journal:  Gastroenterology       Date:  1979-05       Impact factor: 22.682

2.  Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons.

Authors:  B S Drasar; M Shiner; G M McLeod
Journal:  Gastroenterology       Date:  1969-01       Impact factor: 22.682

3.  Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora.

Authors:  S L Gorbach; A G Plaut; L Nahas; L Weinstein; G Spanknebel; R Levitan
Journal:  Gastroenterology       Date:  1967-12       Impact factor: 22.682

4.  Fasting breath hydrogen concentrations in gastric and small-intestinal bacterial overgrowth.

Authors:  S M Riordan; C J McIver; T D Bolin; V M Duncombe
Journal:  Scand J Gastroenterol       Date:  1995-03       Impact factor: 2.423

Review 5.  Bacterial overgrowth of the gastrointestinal tract.

Authors:  P P Toskes
Journal:  Adv Intern Med       Date:  1993

Review 6.  The pathophysiology of intestinal bacterial overgrowth syndromes.

Authors:  R B Drude; C Hines
Journal:  Arch Intern Med       Date:  1980-10

7.  Small-bowel bacterial overgrowth in elderly people: clinical significance and response to treatment.

Authors:  N Y Haboubi; R D Montgomery
Journal:  Age Ageing       Date:  1992-01       Impact factor: 10.668

8.  The diagnosis of small bowel bacterial overgrowth in elderly patients.

Authors:  I P Donald; G Kitchingmam; F Donald; R M Kupfer
Journal:  J Am Geriatr Soc       Date:  1992-07       Impact factor: 5.562

9.  Modifications to the gas-enhanced small bowel barium follow-through using gastrografin and compression.

Authors:  G M Fraser; R D Adam
Journal:  Clin Radiol       Date:  1988-09       Impact factor: 2.350

10.  Multiple selective media for the isolation of anaerobic bacteria from clinical specimens.

Authors:  M W Wren
Journal:  J Clin Pathol       Date:  1980-01       Impact factor: 3.411

View more
  9 in total

1.  Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.

Authors:  Virmeet V. Singh; Phillip P. Toskes
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

2.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 3.  A systematic review of diagnostic tests for small intestinal bacterial overgrowth.

Authors:  Reza Khoshini; Sun-Chuan Dai; Sheila Lezcano; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

4.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A J Wigg; I C Roberts-Thomson; R B Dymock; P J McCarthy; R H Grose; A G Cummins
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 5.  Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.

Authors:  Bushra Aziz Malik; Yuan Y Xie; Eytan Wine; Hien Q Huynh
Journal:  Can J Gastroenterol       Date:  2011-01       Impact factor: 3.522

Review 6.  Evaluation of small bowel bacterial overgrowth.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2007-10

7.  Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.

Authors:  Richard A Schatz; Qing Zhang; Nilesh Lodhia; Jonathan Shuster; Phillip P Toskes; Baharak Moshiree
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 8.  Small bowel bacterial overgrowth: presentation, diagnosis, and treatment.

Authors:  Virmeet V Singh; Phillip P Toskes
Journal:  Curr Gastroenterol Rep       Date:  2003-10

9.  Intestinal microbiota in functional bowel disorders: a Rome foundation report.

Authors:  Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal
Journal:  Gut       Date:  2012-06-22       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.